In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Liposome Co. Inc.

Division of Perrigo Co. PLC

Latest From Liposome Co. Inc.

Call it What You Like

Nuveen announced in September that it began selling a new biotechnology sector fund for retail investors. But only one of the fifteen stocks in the fixed portfolio has a market cap below $2 billion. If money is starting to flow into the biotech sector, Nuveen is still taking no chances with small-caps.
BioPharmaceutical Strategy

Cyclacel Ltd.

With one of the discoverers of p53, David Lane, PhD as its scientific officer, Cyclacel is developing small molecule anti-cancer drugs which target the cell cycle.
BioPharmaceutical Strategy

Delsys Pharmaceutical Corp.

Delsys Pharmaceuticals hopes to simplify the process of drug formulation for pharmaceutical companies with an automated technology called {Accudep}. {Accudep} uses an electrostatic deposition technology to manufacture, using minimal excipients, all sorts of pharmaceuticals based on dry powder.
BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Perrigo Co. PLC
  • Senior Management
  • Charles A Baker, Chmn., Pres. & CEO
    Lawrence R Hoffman, VP, Fin. & CFO
    Donald D Yarson, SVP, World Wide Sales, Mktg. & Bus. Dev.
    Andrew S Janoff, PhD, VP, R&D
  • Contact Info
  • Liposome Co. Inc.
    Phone: (609) 452-7060
    1 Research Way
    Princeton, NJ 08540-